Clinical Trials
6 trialsNCT05588141 2026-06-05
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
National Institutes of Health Clinical Center (CC)
Phase 1/2 Recruiting
NCT07416188 2026-06-05
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Recruiting
NCT00060541 2026-06-01
Evaluation and Treatment of Neurosurgical Disorders
National Institutes of Health Clinical Center (CC)
Recruiting
NCT02639325 2026-05-29
Tumor Related Epilepsy
National Institutes of Health Clinical Center (CC)
Recruiting
NCT07374692 2026-05-22
Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
National Institutes of Health Clinical Center (CC)
Phase NA Recruiting
NCT06161519 2026-05-13
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
National Institutes of Health Clinical Center (CC)
Phase 1/2 Recruiting